Abstract:Background: Hereditary spastic paraplegia is a heterogeneous group of clinically and genetically neurodegenerative diseases characterized by progressive gait disorder. Hereditary spastic paraplegia can be inherited in various ways, and all modes of inheritance are associated with multiple genes or loci. At present, more than 76 disease-causing loci have been identified in hereditary spastic paraplegia patients. Here, we report a novel mutation in SPAST gene associated with hereditary spastic paraplegia in a Chinese family, further enriching the hereditary spastic paraplegia spectrum. Methods: Whole genomic DNA was extracted from peripheral blood of the 15 subjects from a Chinese family using DNA Isolation Kit. The Whole Exome Sequencing of the proband was analyzed and the result was identified in the rest individuals. RaptorX prediction tool and Protein Variation Effect Analyzer were used to predict the effects of the mutation on protein tertiary structure and function. Results: Spastic paraplegia has been inherited across at least four generations in this family, during which only four HSP patients were alive. The results obtained by analyzing the Whole Exome Sequencing of the proband exhibited a novel disease-associated in-frame deletion in the SPAST gene, and the this mutation also existed in the rest three HSP patients in this family. This in-frame deletion consists of three nucleotides deletion (c.1710_1712delGAA) within the exon 16, resulting in lysine deficiency at the position 570 of the protein (p.K570del). This novel mutation was also predicted to result in the synthesis of misfolded SPAST protein and have the deleterious effect on the function of SPAST protein. Conclusion: In this case, we reported a novel mutation in the known SPAST gene that segregated with HSP disease, which can be inherited in each generation. Simultaneously, this novel discovery significantly enriches the mutation spectrum, which provides an opportunity for further investigation of genetic pathogenesis of HSP.

A novel ATP13A2 variant causing complicated hereditary spastic paraplegia

ATP1A3 Mutation in Rapid-Onset Dystonia Parkinsonism: New Data and Genotype-Phenotype Correlation Analysis

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

A Novel Candidate Locus on Chromosome 11P14.1-P11.2 for Autosomal Dominant Hereditary Spastic Paraplegia

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia

Mutations in the ATP13A2 Gene and Parkinsonism: A Preliminary Review

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

A Novel KIF5A Gene Variant Causes Spastic Paraplegia and Cerebellar Ataxia

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

A Novel SPAST Gene Mutation Identified in a Chinese Family with Hereditary Spastic Paraplegia

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

Two Novel Homozygous Mutations of CAPN1 in Chinese Patients with Hereditary Spastic Paraplegia and Literatures Review

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability

Analysis of KIAA0196 gene mutation in a family with hereditary spastic paraplegia

A novel variant causes pure hereditary spastic paraplegia with benign clinical course.